Question 1

Am I eligible for this study based on my migraine treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data clinical trial (NCT01381523). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination treatment compare to the single triptans I have used?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data clinical trial (NCT01381523). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of SumaRT/Nap?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data clinical trial (NCT01381523). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my treatment costs be affected if I participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data clinical trial (NCT01381523). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be involved if I switch treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data clinical trial (NCT01381523). Contact the study team or your healthcare provider for specific answers.

Question 6

Can you explain how this study's findings might impact my future migraine treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data clinical trial (NCT01381523). Contact the study team or your healthcare provider for specific answers.

What this study is about